CHANGE IN CONTROL SEVERANCE AGREEMENTChange in Control Severance Agreement • March 1st, 2021 • ImmunoGen, Inc. • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 1st day of June, 2020 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Stacy A. Coen (the “Executive”).
COLLABORATION AND LICENSE AGREEMENT by and between ImmunoGen, Inc. and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. Dated as of October 19, 2020Collaboration and License Agreement • March 1st, 2021 • ImmunoGen, Inc. • Pharmaceutical preparations • New York
This COLLABORATION AND LICENSE AGREEMENT (this “Agreement”) is made as of October 19, 2020 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (“ImmunoGen”), having a place of business at 830 Winter Street, Waltham, MA 02451, USA, and Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (“Partner”), having a place of business at No. 866, Moganshan Road, GongShu District, Hang Zhou City, Zhejiang Province, People’s Republic of China. ImmunoGen and Partner are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
